Fady Riad, PharmD, MSc
Healthcare - Life Sciences Strategy & Investment Research Consultant
Trained as a PharmD with a master's degree in drug discovery and development, I have years of experience in competitive and market intelligence, M&A and business development, corporate strategy consulting, and commercial due diligence primarily in the pharmaceutical and biotechnology spaces as well as the medical device, healthcare provider, and life sciences equipment industries.Over the last decade, I have had the opportunity to work with some of the world's leading corporations - including top 15 pharma companies.I frequently get featured in the the industry's top publications, from Labiotech to Mergermarket and Inside Precision Medicine.I currently advise hedge funds, private equity firms, investment banks, VC funds, management consulting companies, corporations, and family offices on investment opportunities, strategy, and market trends in the healthcare and life sciences spaces. Looking for expert guidance in these two sectors? Let's get in touch.
Portfolio: Select Case Studies
For confidentiality and compliance purposes, key identifying details and numbers have been altered.
Media Features
CRISPR/Cas9: Outlook from an investor's perspective (Labiotech - 2022)
Six biotech stocks trading below cash right now (Labiotech - 2022)
Gene therapy approval “game changer” in hemophilia B treatment (Labiotech – 2022)
The biggest biotech trends that will shape 2023 (Labiotech – 2023)
5 Clinical-Stage Cell and Gene Therapy Startups Leading the Pack (Inside Precision Medicine - 2023)
5 advancements in kidney disease research over the past year (Labiotech - 2023)
5 advancements in Down syndrome research over the past year (Labiotech - 2023)
European Regenerative Medicine Snapshot: Dealmaking on Uptick (Mergermarket - 2023)
European biotech companies with oncology projects attract Big Pharma (Mergermarket - 2024)
5 Key Startups Bringing Digital Pathology Into Focus (Inside Precision Medicine - 2024)
Contact Me - For Consulting Or Media Requests
Note: I do not provide valuation or financial modeling services. This is not financial or investment advice. I reserve the right to reject engagements in case of conflict of interest or other compliance considerations.